low glutathione levels in parkinson's disease

low glutathione levels in parkinson's disease disease: pathogenesis and therapeutic strategies | Molecular Biomedicine Glutathione Depletion and MicroRNA Dysregulation

Name: low glutathione levels in parkinson's disease disease: pathogenesis and therapeutic strategies | Molecular Biomedicine Glutathione Depletion and MicroRNA Dysregulation
Brand: equiscorp.hu
SKU: 59323281333
Price: 24.92 USD
Availability: InStock
Rating: 4.3519000000000005 (19 reviews)

Glutathione Depletion and MicroRNA Dysregulation in Multiple System Atrophy: A Review Glutathione Decreases ParkinsonismInduced Ferroptosis and Oxidative Stress Through the Inhibition of the TRPM2 Channel in Neuronal Cells Gzel 2025 Pharmacology Research & Perspectives Wiley Online Library low glutathione levels in parkinson's disease Decreases ParkinsonismInduced Ferroptosis and Oxidative Stress Through the Inhibition of the TRPM2 Channel Neuronal Cells Gzel 2025 Pharmacology Research & Perspectives Parkinson's Disease The glutathione system in Parkinson's disease and its progression ScienceDirect

SKU: 59323281333 · From equiscorp.hu

4.4

USD24.92 USD55.92

Pay in 4 interest-free payments of $6.23 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Kelly, F.J., Glutathione: in defence of the lung, Food Chem

During inflammatory processes, triglycerides undergo hydrolysis, forming free fatty acids (FFA) (Zhu et al., 2022), which are toxic to hepatocytes and induce apoptosis through both extrinsic and intrinsic pathways ( (2) Toxic Lipid Metabolites: The metabolism of lipids produces toxic metabolites such as malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), and malondialdehyde-acetaldehyde adducts (MAA), which further damage mitochondria and promote free radical production (Schaffert, 2009)